GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
Clinical trial NCT00866658 · COMPLETED
Trial details
- NCT number
- NCT00866658
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.